Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trial-Reference-Cited by-同舟云学术

Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trial

Published:2023-03-08 Issue:4 Volume:16 Page:363-370
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Xu Zhongnan¹,Liu Zhengzhi²,Wang Yanli²,Xue Jinling¹,Chang Tianying²,Cui Yingzi²,Cheng Yang²,Liu Guangwen²,Wang Wanhua²,Zhou Yannan²,Yu Shuang²,Ren Qing²,Yang Wei²,Qu Xinyao²,Chen Jiahui²,Chen Xuesong³,Deng Qiaohuan²,Yang Haimiao²,Wang Xiuge²

Affiliation:

1. Department of Clinical Research Center, Chia Tai Tianqing Pharmaceutical Group Co.,Ltd, Jiangsu, China

2. Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Jilin, China

3. Quality Control Room of Clinical Trial, Ansiterui Medical Technology Consulting Co., Ltd, Jilin, China

Funder

Chia Tai Tianqing Pharmaceutical Group Co.,Ltd, Jiangsu, China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2188192

Reference39 articles.

1. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

2. Diabetes facts & figures. [updated 2020 Feb 12]. Available from: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html

3. National Diabetes Information Clearinghouse. National diabetes statistics. 2007. [cited 2021 Aug 1]. Available from: http://diabetes.niddk.nih.gov/dm/pubs/statistics/

4. Clinically significant depressive symptoms and high diabetes distress in adults with type 1 and type 2 diabetes in Appalachian Ohio